14-Nov-2026 17:14:52

NATHBIOGENGeneral news

NATHBIOGEN Q2 FY27 ; CONS NET PROFIT DOWN 84.79% AT ₹0.42 CR (YOY), DOWN 98.70% (QOQ)

REVENUE DOWN 7.09% AT ₹40.74 CR (YOY), DOWN 87.59% (QOQ) EBITDA UP 9.28% AT ₹10.67 CR (YOY), DOWN 72.94% (QOQ) MARGINS AT 26.18% VS 22.26% (YOY), 12.00% (QOQ)

Nath Bio-Genes (India) Ltd

Open attachment

← Back to feed